Seldane approval may be withdrawn by FDA.
D017277:Drug Approval; D004347:Drug Interactions; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*; D016593:Terfenadine / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D006634:Histamine H1 Antagonists; D016593:Terfenadine; C093230:fexofenadine